BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 22, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 7, 2007
View Archived Issues
Faster Knockout Identification By Building A Better Haystack
Read More
Proteon Financing Gets $12M To Put Vasodilator Into Clinic
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Respiratory Disease Firm Pearl Raises $15.5M In First Financing
Formed last year to use particle technologies licensed from Nektar Therapeutics Inc. for respiratory drug development, start-up Pearl Therapeutics Inc. pulled in $15.5 million in its first venture-backed financing round. (BioWorld Today)
Read More
Waxman Says Any Biosimilar Pathway 'Must Be Rigorous'
Read More
